Literature DB >> 12755769

Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5-year mean follow-up study of histologically marginal excisions.

S Ghosh1, A Panarese, P D Bull, J A Lee.   

Abstract

The aim of the study was to identify recurrence risk factors in surgically excised parotid pleomorphic salivary adenomas. We reviewed the case histories and histological findings for all cases of marginal or inadequate excision of pleomorphic salivary adenomas at the Royal Hallamshire Hospital, Sheffield, UK, between 1980 and 1995. A total of 83 cases with complete records were identified, with a mean follow-up period of 12.5 years. The histological slides were reviewed in each case. The overall recurrence rate was 6.0%. Where tumour was present at the margin, recurrence occurred in 17.6% of cases. However, cases conventionally regarded as marginally excised and likely to recur (tissue margin < 1 mm) showed recurrence in only 1.8% of cases. Intraoperative capsular rupture, microscopic capsular invasion by tumour and several other surgical factors were not predictive of recurrence. Adequate excision of pleomorphic salivary adenomas, in the sense of minimal recurrence risk, does not require more than a fraction of a millimetre of surrounding tissue. Only pleomorphic salivary adenomas with tumour actually at the excision margin require prolonged follow-up or consideration of radiotherapy. Provided that the tumour can be removed intact, the surgical approach for pleomorphic salivary adenomas should be guided by the need to preserve vital structures rather than by an attempt to remove a cuff of normal tissue with the tumour.

Entities:  

Mesh:

Year:  2003        PMID: 12755769     DOI: 10.1046/j.1365-2273.2003.00704.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  13 in total

Review 1.  Surgical options in benign parotid tumors: a proposal for classification.

Authors:  Miquel Quer; Vincent Vander Poorten; Robert P Takes; Carl E Silver; Carsten C Boedeker; Remco de Bree; Alessandra Rinaldo; Alvaro Sanabria; Ashok R Shaha; Albert Pujol; Peter Zbären; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-21       Impact factor: 2.503

2.  Benign parotid tumours.

Authors:  Mark McGurk
Journal:  BMJ       Date:  2004-12-04

3.  Clinicopathologic Characteristics and Prognostic Factors of Primary and Recurrent Pleomorphic Adenoma: A Single Institution Retrospective Study of 705 Cases.

Authors:  Bayan Alzumaili; Bin Xu; Maelle Saliba; Abderhman Abuhashem; Ian Ganly; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2021-11-15       Impact factor: 6.298

Review 4.  Parotid surgery for benign tumours.

Authors:  Farzad Borumandi; Katherine S George; Luke Cascarini
Journal:  Oral Maxillofac Surg       Date:  2012-07-31

5.  Satellite tumors surrounding primary pleomorphic adenomas of the parotid gland.

Authors:  Yorihisa Orita; Kazuo Hamaya; Kentaroh Miki; Akiko Sugaya; Misato Hirai; Kiyoko Nakai; Sohichiroh Nose; Tadashi Yoshino
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-07       Impact factor: 2.503

6.  Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis.

Authors:  Masanari G Kato; Evren Erkul; Shaun A Nguyen; Terry A Day; Joshua D Hornig; Eric J Lentsch; M Boyd Gillespie
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-11-01       Impact factor: 6.223

Review 7.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

8.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

9.  Parotid pleomorphic and non-pleomorphic adenomas: a mono-institutional series of 512 patients.

Authors:  Davide Lombardi; Michele Tomasoni; Alessio Nicolai; Alberto Paderno; Alberto Grammatica; Mara Arcuri; Davide Lancini; Simonetta Battocchio; Laura Ardighieri; Anna Bozzola; Frida Pittiani; Davide Farina; Luca Oscar Redaelli de Zinis; Piero Nicolai; Cesare Piazza
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-08-05       Impact factor: 2.503

Review 10.  PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients.

Authors:  Shang Xie; Kan Wang; Hui Xu; Rui-Xi Hua; Tian-Zhu Li; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.